Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

There are bidirectional associations for sleep disorders with chronic kidney disease (CKD), according to a review published ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

Air pollution harms our kidneys. Studies show a link between air pollution and kidney disease. A study found that air ...

Archer Materials (ASX:AXE) has announced progress in its development of graphene field effect transistor (gFET) sensors for ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...

Tom Nolan reviews this week’s research Many people with osteoporosis are unable to tolerate oral bisphosphonates—many others would prefer a six monthly denosumab injection to a once weekly pill that ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...